NCT02746237View on ClinicalTrials.gov

Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

August 31, 2016

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

KAR5585 Capsules

Single and multiple ascending doses of KAR5585 (100 mg initial dose)

DRUG

Placebo Capsules

Single and multiple ascending doses of placebo (100 mg initial dose)

Trial Locations (1)

53095

Spaulding Clinical, West Bend

Sponsors
All Listed Sponsors
lead

Karos Pharmaceuticals

INDUSTRY